Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy

NCT05918224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Streptococcus salivarius K12
DRUG: Streptococcus salivarius K12 simulants

Sponsor

West China Hospital